ADMA Biologics, Inc.
USD7.76
+0.16 (+2.11%)
CEO
Adam S. Grossman
IPO Date
2013-10-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.53
Prev. Close
$7.60
Day Low
$7.46
Day High
$7.79
52W Low
$7.21
52W High
$22.37
Market Cap
$1.80B
Volume
2.81M
| 12,500 |
| $8.01 |
| 12 May 2026 | Grossman Jerrold B | director | P-Purchase | Acquired | 12,500 | $8.01 |
| 3 Apr 2026 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | F-InKind | Disposed | 20,362 | $9.11 |
| 17 Mar 2026 | Guiheen Lawrence P. | director | M-Exempt | Acquired | 30,000 | $3.66 |
| 17 Mar 2026 | Guiheen Lawrence P. | director | G-Gift | Disposed | 30,000 | $0.00 |
| 17 Mar 2026 | Guiheen Lawrence P. | director | G-Gift | Acquired | 30,000 | $0.00 |
| 17 Mar 2026 | Guiheen Lawrence P. | director | M-Exempt | Disposed | 30,000 | $3.66 |
| 17 Mar 2026 | Grossman Adam S | director, officer: President and CEO | M-Exempt | Acquired | 15,000 | $5.40 |
| 17 Mar 2026 | Grossman Adam S | director, officer: President and CEO | S-Sale | Disposed | 15,000 | $15.16 |